Jeudi, 29 Octobre 2020
Dernières nouvelles
Principale » MiMedx Group, Inc (MDXG) Receives Average Recommendation of "Buy" from Brokerages

MiMedx Group, Inc (MDXG) Receives Average Recommendation of "Buy" from Brokerages

24 Juin 2017

The stock's traded 1.8 million shares in session while it holds an average volume of 1.53 million shares. Following the transaction, the insider now owns 533,612 shares of the company's stock, valued at $7,331,828.88. It is down 28.96% since June 21, 2016 and is downtrending. Insiders own 12.40% of the company's stock. It has outperformed by 15.08% the S&P500.

In terms of Buy, Sell or Hold recommendations, Mimedx Group Inc (NASDAQ:MDXG) has analysts' mean recommendation of 2.6. Therefore 22% are positive. MiMedx Group had 10 analyst reports since July 29, 2015 according to SRatingsIntel.

12/17/2015 - MiMedx Group, Inc had its "buy" rating reiterated by analysts at Brean Capital. The stock has "Overweight" rating by First Analysis on Wednesday, January 20. The rating was upgraded by Needham on Monday, November 16 to "Strong Buy". Needham maintained the stock with "Buy" rating in Wednesday, October 14 report. As per Tuesday, May 23, the company rating was downgraded by First Analysis. The firm has "Buy" rating given on Friday, December 18 by Canaccord Genuity. The firm has "Buy" rating by Lake Street given on Tuesday, April 19. The rating was downgraded by Needham on Wednesday, July 29 to "Buy".

MiMedx Group, Inc.is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants human placental tissue, skin and bone. The Company's Regenerative Biomaterials segment includes the design, manufacture, and marketing of products and tissue processing services for the Wound Care, Surgical, Sports Medicine, Ophthalmic and Dental market categories. It has a 115.98 P/E ratio. The Company's biomaterial platform technologies include AmnioFix, EpiFix, OrthoFlo, Physio, AlloBurn, and CollaFix.

Since March 6, 2017, it had 0 insider buys, and 4 insider sales for $2.17 million activity. Shares for $429,136 were sold by KOOB CHARLES E on Monday, March 13.

Trending Stock Analysis Report: Celsion Corp (NASDAQ:CLSN)
Celsion Corporation (CLSN ) reported sales (ttm) of 500000, whereas, 3 number of analysts estimated the mean sale of 0.09 million. The company has mean EPS estimate of -0.73 reported by 3 number of analyst for the quarter ending Current Qtr.(Jun2017).

Mimedx Group Inc (NASDAQ:MDXG) shares traded on 1.28% up secure line and closed at $15.06.

Investors sentiment increased to 1.22 in 2016 Q4. The company has Beta Value of 1.03 and ATR value of 0.59. 23 funds opened positions while 54 raised stakes. Nordea Mngmt holds 0% or 4,953 shares. Northwestern Mutual Wealth Mgmt Co has 0% invested in MiMedx Group Inc (NASDAQ:MDXG) for 1,000 shares. 352,307 were accumulated by Qs Invsts Limited Liability Com. Blackrock Japan Communications holds 207 shares or 0% of its portfolio. (NYSE:WSM). Illinois-based Magnetar Fin Limited Liability has invested 0.01% in Williams-Sonoma, Inc. Moreover, Amalgamated State Bank has 0.01% invested in MiMedx Group Inc (NASDAQ:MDXG). Murphy Mgmt Inc holds 0.03% or 22,700 shares in its portfolio. Dupont Capital Corp has 0.04% invested in MiMedx Group Inc (NASDAQ:MDXG) for 218,712 shares. Merriman Wealth Ltd owns 572,644 shares.

More news for MiMedx Group Inc (NASDAQ:MDXG) were recently published by: Prnewswire.com, which released: "MiMedx to Present at the Jefferies 2017 Global Healthcare Conference" on June 01, 2017.

WARNING: "MiMedx Group, Inc (MDXG) Receives Consensus Recommendation of "Buy" from Brokerages" was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. Over the past 2 quarters, the stock is up 63.87%, compared with a gain of almost 70.17% for 3 months and about 4.58% for the past 30 days. Northern, a Illinois-based fund reported 1.40 million shares. It has outperformed by 91.17% the S&P500. It also upped Sabre Corp (NASDAQ:SABR) stake by 199,483 shares and now owns 6.67M shares. Therefore 17% are positive. Inc. had 36 analyst reports since August 13, 2015 according to SRatingsIntel. RBC Capital Markets maintained Amphenol Corporation (NYSE:APH) rating on Thursday, October 22. The stock has "Neutral" rating by UBS on Tuesday, February 16. Piper Jaffray maintained the stock with "Overweight" rating in Monday, December 7 report. ValuEngine upgraded the shares of LEJU in report on Friday, May 26 to "Sell" rating. Goldman Sachs Gp stated it has 256,537 shares. FBR Capital has "Outperform" rating and $5 target. The rating was maintained by RBC Capital Markets on Friday, January 15 with "Top Pick".

Investors sentiment decreased to 1.14 in 2016 Q4. Its down 0.64, from 1.5 in 2016Q3. It is negative, as 23 investors sold AXS shares while 119 reduced holdings. 3 funds opened positions while 3 raised stakes. Citigroup Inc holds 16,884 shares. Stevens First Principles Inv, California-based fund reported 1,000 shares. Deutsche Financial Bank Ag holds 0% or 82,480 shares. Gareth Morgan Partnership holds 41,727 shares. Henderson Grp Public Limited Co holds 318,765 shares. Lincoln National reported 16,055 shares. Fjarde Ap invested in 0.04% or 25,799 shares. Texas Permanent School Fund owned approximately 0.07% of MiMedx Group worth $690,000 as of its most recent SEC filing. Comml Bank Of America De reported 176,212 shares. Invesco Limited owns 252,724 shares or 0% of their United States portfolio. 31,600 are owned by Pictet Asset Mgmt. Alliancebernstein L P stated it has 0% in Auburn National Bancorporation Inc (NASDAQ:AUBN). During the same period in the prior year, the firm earned $0.04 earnings per share.